SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-059768
Filing Date
2024-05-14
Accepted
2024-05-14 17:06:23
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q apto-20240331.htm   iXBRL 10-Q 1283227
2 EX-31.1 apto-ex31_1.htm EX-31.1 15138
3 EX-31.2 apto-ex31_2.htm EX-31.2 12037
4 EX-32.1 apto-ex32_1.htm EX-32.1 6129
5 EX-32.2 apto-ex32_2.htm EX-32.2 6134
6 GRAPHIC img239725604_0.jpg GRAPHIC 5225
  Complete submission text file 0000950170-24-059768.txt   6279062

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT apto-20240331.xsd EX-101.SCH 1170142
69 EXTRACTED XBRL INSTANCE DOCUMENT apto-20240331_htm.xml XML 977302
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32001 | Film No.: 24945585
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)